![Joseph Slattery](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Slattery
Director/Board Member at
REPLIMUNE GROUP, INC.
Net worth: 371 673 $ as of 2026-05-30
Profile
Mr. Joseph P.
Slattery, CPA, is an Independent Director at Replimune Group, Inc., a Lead Independent Director at CVRx, Inc. and a Member at Virginia Society of Certified Public Accountants.
He is on the Board of Directors at ImageneBio, Inc., Morphic Therapeutic, Inc., Replimune Group, Inc. and CVRx, Inc. Mr. Slattery was previously employed as an Independent Director by Omega Alpha SPAC, an Independent Director by Morphic Holding, Inc., a CFO, Chief Accounting Officer & EVP by TransEnterix, Inc., a Chief Financial Officer & Executive Vice President by SafeStitch Medical, Inc., a Chief Financial Officer & Executive Vice President by TransEnterix, Inc. /Old/, an Independent Director by Micromet, Inc. /MD/, a Chief Financial Officer & Executive Vice President by Baxano Surgical, Inc., a Chief Financial Officer & SVP-Information Systems by Digene Corp., a Staff Auditor by Ernst & Young LLP, and an Audit Manager by KPMG LLP.
He also served on the board at Exosome Diagnostics, Inc. and Micromet, Inc. He received his undergraduate degree from Bentley University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CVRX, INC. 0.15% | 2026-05-31 | 39,365 ( 0.15% ) | 219 657 $ | 2026-05-30 |
0.14% | 2026-04-27 | 16,000 ( 0.14% ) | 94 080 $ | 2026-05-30 |
| 2026-03-31 | 6,667 ( 0.01% ) | 57 936 $ | 2026-05-30 |
Joseph Slattery active positions
| Companies | Position | Start |
|---|---|---|
| CVRX, INC. | Director/Board Member | 2008-09-30 |
| REPLIMUNE GROUP, INC. | Director/Board Member | 2017-09-30 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Director/Board Member | 2019-04-30 |
Virginia Society of Certified Public Accountants | Corporate Officer/Principal | 2010-06-27 |
Former positions of Joseph Slattery
| Companies | Position | End |
|---|---|---|
| MORC HOLD | Director/Board Member | 2024-08-15 |
| ASENSUS SURGICAL, INC. | Director of Finance/CFO | 2019-12-30 |
TransEnterix, Inc. /Old/
 TransEnterix, Inc. /Old/ Medical SpecialtiesHealth Technology Develops tools and technique for gastro-intestinal surgical procedure | Director of Finance/CFO | 2019-11-30 |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Director/Board Member | 2017-12-31 |
SafeStitch Medical, Inc.
 SafeStitch Medical, Inc. Medical SpecialtiesHealth Technology Produces medical devices | Director of Finance/CFO | 2013-12-08 |
Training of Joseph Slattery
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Digene Corp.
 Digene Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets DNA and RNA tests | Electronic Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
TransEnterix, Inc. /Old/
TransEnterix, Inc. /Old/ Medical SpecialtiesHealth Technology Develops tools and technique for gastro-intestinal surgical procedure | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CVRx, Inc.
 CVRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes neuromodulation device & implantable technology to treat hypertension and heart failure | Health Technology |
TranS1, Inc.
 TranS1, Inc. Medical SpecialtiesHealth Technology Designs and develops surgical procedures and equipment for back pain | Health Technology |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Virginia Society of Certified Public Accountants | |
SafeStitch Medical, Inc.
SafeStitch Medical, Inc. Medical SpecialtiesHealth Technology Produces medical devices | Health Technology |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Health Services |
Asensus Surgical, Inc.
 Asensus Surgical, Inc. Packaged SoftwareTechnology Services Develops digital and robotic-assisted surgical systems | Technology Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Omega Alpha SPAC
 Omega Alpha SPAC Financial ConglomeratesFinance Operates as a blank check company | Finance |
Micromet Inc.
 Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Joseph Slattery
